Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2-breast cancer: comparison to the morphological and pathological response

被引:0
|
作者
Boughdad, Sarah [1 ]
Champion, Laurence [1 ]
Becette, Veronique [2 ]
Cherel, Pascal [2 ]
Mouret-Fourme, Emmanuelle [2 ]
Edeline, Veronique [1 ]
Lemonnier, Jerome [3 ]
Lerebours, Florence [2 ]
Alberini, Jean-Louis [1 ]
机构
[1] Ctr Rene Huguenin, Inst Curie, Nucl Med, St Cloud, France
[2] Ctr Rene Huguenin, Inst Curie, St Cloud, France
[3] Unicancer, Paris, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1311
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The EndoPredict score identifies late distant metastases in ER+/HER2-breast cancer patients
    Dubsky, P.
    Brase, J. C.
    Fisch, K.
    Jakesz, R.
    Singer, C. F.
    Greil, R.
    Dietze, O.
    Weber, K. E.
    Petry, C.
    Kronenwett, R.
    Rudas, M.
    Knauer, M.
    Gnant, M.
    Filipits, M.
    CANCER RESEARCH, 2012, 72
  • [42] Femara plus ribociclib or placebo as neoadjuvant endocrine therapy for women with ER+, HER2-negative early breast cancer - The Feline trial
    Khan, Q. J.
    Prochaska, L. H.
    Mohammad, J.
    Yuan, Y.
    O'Dea, A.
    Bardia, A.
    Wisinski, K.
    Hard, M.
    Baccaray, S.
    Makhoul, I.
    Wagner, J.
    Laura, S.
    Ma, C.
    Sharma, P.
    CANCER RESEARCH, 2017, 77
  • [43] Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer
    Kristoffer B. Kristensen
    Ida Marie Nedergaard Thomsen
    Tobias Berg
    Annette R. Kodahl
    Anders Bonde Jensen
    Breast Cancer Research and Treatment, 2021, 188 : 799 - 809
  • [44] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ryu, Ho Hyun
    Ahn, Sei Hyun
    Kim, Seon Ok
    Kim, Jeong Eun
    Kim, Ji Sun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Shin, Hee Jung
    Kim, Hak Hee
    Gong, Gyung Yub
    Kim, Hee Jeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Patricia Cortazar
    Charles E. Geyer
    Annals of Surgical Oncology, 2015, 22 : 1441 - 1446
  • [46] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Cortazar, Patricia
    Geyer, Charles E., Jr.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1441 - 1446
  • [47] Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
    Olukoya, Ayodeji O.
    Stires, Hillary
    Bahnassy, Shaymaa
    Persaud, Sonali
    Guerra, Yanira
    Ranjit, Suman
    Ma, Shihong
    Cruz, M. Idalia
    Benitez, Carlos
    Rozeboom, Aaron M.
    Ceuleers, Hannah
    Berry, Deborah L.
    Jacobsen, Britta M.
    Raj, Ganesh V.
    Riggins, Rebecca B.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (10)
  • [48] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ho Hyun Ryu
    Sei Hyun Ahn
    Seon Ok Kim
    Jeong Eun Kim
    Ji sun Kim
    Jin-Hee Ahn
    Kyung Hae Jung
    Sung-Bae Kim
    Beom Seok Ko
    Jong Won Lee
    Byung Ho Son
    Hee Jung Shin
    Hak Hee Kim
    Gyung yub Gong
    Hee Jeong Kim
    Scientific Reports, 11
  • [49] PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2-breast cancer
    Ozcan, Gulnihal
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] The Pathological Response of Her2+Breast Cancer with Neoadjuvant Chemotherapy and Radiation Therapy
    Chao, M.
    Baker, C.
    Jassal, S.
    Law, M.
    Bevington, E.
    Stoney, D.
    Zantuck, N.
    Chew, G.
    Loh, S. W.
    Hyett, A.
    Guerrieri, M.
    Ng, M.
    Cokelek, M.
    Neoh, D.
    Yong, C.
    Ho, H.
    Tacey, M.
    Joon, D. Lim
    Khor, R.
    Foroudi, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E17 - E17